Skip to article
Astra

Hypertension

Resistant Hypertension Secondary Cause Testing

In apparent resistant hypertension, first confirm sustained out-of-office blood pressure elevation and treatment exposure, then pursue targeted testing for primary aldosteronism, obstructive sleep apnea, kidney disease, renovascular disease, medication effects, and selected endocrine disorders.

Clinical question: Which secondary-cause tests should be ordered after confirming apparent resistant hypertension?

First decision

Confirm true resistant hypertension before secondary-cause testing

Apparent resistance becomes actionable only after out-of-office confirmation and regimen review.

Classify the patient as having apparent treatment-resistant hypertension when blood pressure remains uncontrolled despite at least 3 concurrently prescribed antihypertensive agents at optimized doses, including a diuretic, or when control requires at least 4 agents.AHA JournalsResistant Hypertension: Diagnosis, Evaluation, and TreatmentWileyAssociated factors and hemodynamic characteristics of resistant hypertension in the elderlyWolters KluwerPrimary hyperaldosteronism presenting as... : Medicine: Case Reports and Study Protocols Before assigning true resistance, review the medication list for a long-acting thiazide or thiazide-like diuretic and establish whether each prescribed agent is being taken; multidrug nonadherence is specifically recognized as a setting in which device-based therapy should not substitute for correcting the underlying problem.Nature2022 Renal denervation therapy for the treatment of hypertension

Obtain ambulatory blood pressure monitoring (ABPM) when available to confirm uncontrolled hypertension, identify white-coat hypertension, assess nocturnal hypertension or nondipping, and determine whether pressure is controlled across the full 24-hour dosing interval.Wolters Kluwer2021 European Society of Hypertension practice... : Journal of Hypertension Home blood pressure monitoring is the practical alternative for longitudinal follow-up and detection of white-coat or masked hypertension.Wolters Kluwer2021 European Society of Hypertension practice... : Journal of Hypertension Do not initiate an extensive secondary-hypertension evaluation solely from persistently elevated office values when ABPM or reliable home readings do not confirm sustained elevation.

At the same encounter, identify reversible exogenous contributors by reconciling prescription drugs, over-the-counter agents, supplements, alcohol and other substances. Drug causes were included in systematic evaluations of resistant hypertension alongside sleep apnea, primary aldosteronism, renal disease, renovascular disease, pheochromocytoma, Cushing syndrome, coarctation, and thyroid disorders.AHA JournalsObstructive Sleep Apnea | Hypertension The finding of a likely drug contributor should prompt withdrawal or substitution when feasible, followed by reassessment with home blood pressure monitoring before escalating to invasive testing.

Tests that establish whether apparent resistant hypertension warrants a secondary-cause workup.AHA JournalsResistant Hypertension: Diagnosis, Evaluation, and TreatmentWolters Kluwer2021 European Society of Hypertension practice... : Journal of HypertensionWileyAssociated factors and hemodynamic characteristics of resistant hypertension in the elderly
FindingTest or reviewInterpretation and next action
Persistent office hypertension on 3 or more agentsABPM; use home blood pressure monitoring if ABPM is unavailableConfirm sustained uncontrolled blood pressure before labeling true resistant hypertension; assess nighttime control and possible white-coat effect.Wolters Kluwer2021 European Society of Hypertension practice... : Journal of Hypertension
Blood pressure controlled only with 4 or more agentsMedication and adherence review plus out-of-office blood pressure assessmentMeets resistant-hypertension definition despite controlled clinic blood pressure; proceed with a structured secondary-cause screen when true resistance is confirmed.WileyAssociated factors and hemodynamic characteristics of resistant hypertension in the elderlyWolters KluwerPrimary hyperaldosteronism presenting as... : Medicine: Case Reports and Study Protocols
No diuretic or nonoptimized multidrug regimenReconcile doses, timing, tolerability, and diuretic exposureOptimize the foundational regimen before interpreting treatment failure as biologic resistance.AHA JournalsResistant Hypertension: Diagnosis, Evaluation, and TreatmentNature2022 Renal denervation therapy for the treatment of hypertension
Suspected nonadherence or multidrug intoleranceDirect medication history and regimen simplification where possibleCorrect exposure barriers before considering invasive escalation such as renal denervation.Nature2022 Renal denervation therapy for the treatment of hypertension

Initial panel

Use baseline phenotype to select the secondary-cause branch

A focused initial panel separates renal, aldosterone-mediated, sleep-related, and catecholamine or thyroid patterns.

Obtain serum potassium, renal function testing, and a targeted renal and endocrine evaluation in confirmed resistant hypertension. In published resistant-hypertension evaluations, the secondary workup included serum potassium, renin, aldosterone, plasma metanephrines, thyroid function tests, 24-hour urinary potassium, renal artery ultrasonography or computed tomography angiography, adrenal CT or MRI, and polysomnography, selected according to history, examination, and baseline laboratory findings.WileyAssociated factors and hemodynamic characteristics of resistant hypertension in the elderly

Do not use hypokalemia as a gatekeeper for primary aldosteronism testing. Primary aldosteronism commonly presents as hypertension without classical hypokalemia, and multiple hypertension and endocrine societies recommend aldosterone-to-renin screening in resistant hypertension.AHA JournalsScreening Rates for Primary Aldosteronism in Resistant Hypertension | Hypertension Conversely, potassium status, sodium loading, pregnancy, antihypertensive drugs, obstructive sleep apnea, and renal insufficiency can alter the aldosterone-renin ratio (ARR), including producing false-negative results.Wolters KluwerCase series: Primary aldosteronism diagnosed despite normal ... : Medicine

Use the clinical phenotype to sequence testing. Kidney dysfunction or urinalysis abnormalities should move renal parenchymal disease forward; a low-renin aldosterone-mediated pattern should move primary aldosteronism forward; snoring, witnessed apnea, daytime somnolence, or nocturnal blood pressure abnormalities should move sleep testing forward; and paroxysmal hyperadrenergic spells, a suggestive family history, or an adrenal mass should move metanephrine testing forward.AHA JournalsObstructive Sleep Apnea | HypertensionScienceDirectRenovascular Disease - an overviewWileyAssociated factors and hemodynamic characteristics of resistant hypertension in the elderly

Phenotype-directed testing for common and consequential secondary causes in resistant hypertension.AHA JournalsObstructive Sleep Apnea | HypertensionScienceDirectRenovascular Disease - an overviewWileyAssociated factors and hemodynamic characteristics of resistant hypertension in the elderlyWolters KluwerClinical practice guideline for the management of hypertension in ...
Clinical or laboratory clueFirst targeted testResult that changes the next step
Resistant hypertension with or without hypokalemiaPlasma aldosterone-to-renin ratioA positive screen requires primary-aldosteronism confirmation and subtype evaluation; do not dismiss the condition because potassium is normal.AHA JournalsScreening Rates for Primary Aldosteronism in Resistant Hypertension | HypertensionWolters KluwerCase series: Primary aldosteronism diagnosed despite normal ... : Medicine
Snoring, witnessed apnea, daytime sleepiness, obesity, nondipping or nocturnal hypertensionSleep study, typically polysomnographySleep-disordered breathing supports obstructive sleep apnea as a treatable contributor; apnea-hypopnea index greater than 15 events/hour defined OSA in a resistant-hypertension cohort.AHA JournalsObstructive Sleep Apnea | HypertensionWileyAssociated factors and hemodynamic characteristics of resistant hypertension in the elderly
Reduced kidney function, albuminuria, urinary abnormalities, or longstanding renal diseaseRenal function assessment and kidney-directed evaluationPrioritize renal parenchymal disease and volume-related contributors; CKD frequently coexists with resistant hypertension.AHA JournalsResistant Hypertension: Diagnosis, Evaluation, and TreatmentScienceDirectThe double challenge of resistant hypertension and chronic kidney disease - ScienceDirectWileyAssociated factors and hemodynamic characteristics of resistant hypertension in the elderly
Abrupt or severe hypertension with renovascular featuresRenal artery ultrasound or computed tomography angiographyAnatomic renal artery disease redirects evaluation toward renovascular hypertension and an individualized revascularization assessment.WileyAssociated factors and hemodynamic characteristics of resistant hypertension in the elderly
Hyperadrenergic spells, adrenal lesion, hereditary predisposition, or previous pheochromocytomaPlasma-free metanephrines or 24-hour urinary fractionated metanephrinesBiochemical evidence should prompt adrenal or extra-adrenal localization and endocrine-directed management.ScienceDirectRenovascular Disease - an overview
Early-onset hypertension, especially before age 40 years, or blood pressure above 160/100 mm HgBroaden secondary-hypertension screening based on phenotypeEarly onset or marked hypertension increases the indication to investigate obstructive sleep apnea, renovascular disease, primary aldosteronism, renal disease, and other causes.Wolters KluwerClinical practice guideline for the management of hypertension in ...

Highest-yield endocrine test

Screen primary aldosteronism with aldosterone-to-renin testing

Resistant hypertension is a guideline-supported indication for ARR screening.

Obtain plasma aldosterone and renin together and interpret the ARR as a screening test, not as a standalone subtype diagnosis. Resistant hypertension is a consistent indication because national and international societies recommend screening this group with a plasma aldosterone-to-plasma renin activity ratio.AHA JournalsScreening Rates for Primary Aldosteronism in Resistant Hypertension | Hypertension A suppressed renin result with inappropriately elevated aldosterone should lead to confirmatory testing and endocrine referral rather than empiric attribution to essential hypertension.

Correct and document potassium status before interpreting a negative screen. Negative ARR results can occur with altered potassium status, sodium loading, pregnancy, antihypertensive drugs, obstructive sleep apnea, and renal insufficiency; renal vascular injury may permit renin escape and obscure the expected suppression pattern.Wolters KluwerCase series: Primary aldosteronism diagnosed despite normal ... : Medicine If the pretest probability remains high after a negative or equivocal test—particularly with resistant hypertension and hypokalemia—repeat biochemical evaluation under conditions that address modifiable interferents.

After biochemical confirmation, use adrenal imaging and adrenal venous sampling when determining whether unilateral adrenalectomy is appropriate. A published diagnostic pathway for primary aldosteronism used confirmatory testing followed by bilateral adrenal venous sampling to establish lateralization.cellSuccessful treatment of resistant hypertension and severe complications in a 63-year-old man with primary aldosteronism without adrenalectomy: A case report This distinction matters because, in appropriately selected surgically correctable primary aldosteronism, adrenalectomy compared with empiric medical therapy was associated with lower all-cause mortality, longer freedom from atrial fibrillation, and less chronic kidney disease.AHA JournalsScreening Rates for Primary Aldosteronism in Resistant Hypertension | Hypertension

Primary aldosteronism testing sequence in resistant hypertension.AHA JournalsScreening Rates for Primary Aldosteronism in Resistant Hypertension | HypertensioncellSuccessful treatment of resistant hypertension and severe complications in a 63-year-old man with primary aldosteronism without adrenalectomy: A case reportWolters KluwerCase series: Primary aldosteronism diagnosed despite normal ... : Medicine
StepActionPitfall or decision consequence
ScreenMeasure plasma aldosterone and renin; calculate ARRResistant hypertension warrants screening even without hypokalemia.AHA JournalsScreening Rates for Primary Aldosteronism in Resistant Hypertension | Hypertension
ValidateReview potassium status, sodium exposure, pregnancy, renal function, obstructive sleep apnea, and antihypertensive drugsEach can alter ARR interpretation and contribute to a false-negative result.Wolters KluwerCase series: Primary aldosteronism diagnosed despite normal ... : Medicine
ConfirmPerform confirmatory testing after a positive biochemical screenConfirmation distinguishes persistent autonomous aldosterone excess from a screening abnormality.cellSuccessful treatment of resistant hypertension and severe complications in a 63-year-old man with primary aldosteronism without adrenalectomy: A case report
SubtypeUse adrenal imaging and bilateral adrenal venous sampling when surgery is being consideredLateralization identifies patients who may benefit from unilateral adrenalectomy rather than empiric medical treatment.AHA JournalsScreening Rates for Primary Aldosteronism in Resistant Hypertension | HypertensioncellSuccessful treatment of resistant hypertension and severe complications in a 63-year-old man with primary aldosteronism without adrenalectomy: A case report

Common competing branches

Test sleep apnea, renal disease, and renovascular disease according to phenotype

These causes often coexist; one positive test should not terminate evaluation when the blood pressure pattern remains discordant.

Evaluate obstructive sleep apnea early in resistant hypertension. In a cohort in which patients underwent systematic testing regardless of symptoms, obstructive sleep apnea defined by an apnea-hypopnea index greater than 15 events/hour was found in 64.0%, compared with 5.6% for primary aldosteronism, 2.4% for renal artery stenosis, and 1.6% for renal parenchymal disease.AHA JournalsObstructive Sleep Apnea | Hypertension Order polysomnography or another appropriate sleep study when the sleep history, examination, nocturnal blood pressure pattern, or high resistant-hypertension pretest probability supports the diagnosis.ScienceDirectSecondary hypertension: Obstructive sleep apnea - ScienceDirectWileyAssociated factors and hemodynamic characteristics of resistant hypertension in the elderly

Assess for renal parenchymal disease with renal function testing and kidney-directed clinical evaluation, then use urine findings and the broader renal phenotype to guide next testing. Renal parenchymal disease and chronic kidney disease are repeatedly identified secondary or contributing conditions in resistant hypertension.AHA JournalsResistant Hypertension: Diagnosis, Evaluation, and TreatmentScienceDirectThe double challenge of resistant hypertension and chronic kidney disease - ScienceDirectWileyAssociated factors and hemodynamic characteristics of resistant hypertension in the elderly In CKD, volume retention and altered renin-aldosterone physiology can coexist, so a renal explanation does not automatically exclude primary aldosteronism.Wolters KluwerCase series: Primary aldosteronism diagnosed despite normal ... : Medicine

Reserve renal artery imaging for patients with a clinical renovascular phenotype rather than using it as universal screening. Renal artery ultrasonography and CT angiography are established modalities used in resistant-hypertension secondary-cause assessments.WileyAssociated factors and hemodynamic characteristics of resistant hypertension in the elderly If imaging identifies renal artery disease, interpret it in context: atherosclerosis is the most common cause of renovascular hypertension, while fibromuscular and other arterial abnormalities remain relevant etiologies in selected patients.ScienceDirectRenovascular Disease - an overview

Practical differentiation of sleep, renal, and renovascular contributors.AHA JournalsObstructive Sleep Apnea | HypertensionWolters Kluwer2021 European Society of Hypertension practice... : Journal of HypertensionScienceDirectRenovascular Disease - an overviewWileyAssociated factors and hemodynamic characteristics of resistant hypertension in the elderly
Etiologic branchMost useful next testInterpretation
Obstructive sleep apneaPolysomnography or appropriate sleep study; ABPM when nocturnal pattern is relevantAn apnea-hypopnea index greater than 15 events/hour was the threshold used to define OSA in a resistant-hypertension cohort; ABPM identifies nocturnal hypertension and nondipping.AHA JournalsObstructive Sleep Apnea | HypertensionWolters Kluwer2021 European Society of Hypertension practice... : Journal of Hypertension
Renal parenchymal diseaseRenal function assessment with kidney-directed evaluationCKD and renal parenchymal disease can sustain resistant hypertension and complicate renin-aldosterone interpretation.ScienceDirectThe double challenge of resistant hypertension and chronic kidney disease - ScienceDirectWileyAssociated factors and hemodynamic characteristics of resistant hypertension in the elderlyWolters KluwerCase series: Primary aldosteronism diagnosed despite normal ... : Medicine
Renovascular hypertensionRenal artery ultrasonography or CT angiographyPositive anatomic findings support a renovascular branch; atherosclerosis is the most common renovascular cause.ScienceDirectRenovascular Disease - an overviewWileyAssociated factors and hemodynamic characteristics of resistant hypertension in the elderly
Aortic coarctationFocused vascular examination followed by anatomic imaging when suspectedUpper-extremity hypertension with evidence of obstruction should prompt evaluation because renal hypoperfusion can activate RAAS.ScienceDirectRenovascular Disease - an overview

Selective testing

Reserve uncommon endocrine testing and procedures for a compatible phenotype

Testing intensity should rise with pretest probability and the prospect of cause-directed intervention.

Order metanephrine testing when resistant hypertension is accompanied by hyperadrenergic spells, an adrenal mass with imaging features concerning for pheochromocytoma, family history, a predisposing genetic syndrome, or prior pheochromocytoma. Plasma-free metanephrines may be slightly more sensitive but less specific than 24-hour urinary fractionated metanephrines; urine testing is an option when pretest probability is lower, while plasma testing is favored by some experts when it is higher.ScienceDirectRenovascular Disease - an overview A positive biochemical result should trigger localization and endocrine management rather than empiric antihypertensive escalation alone.

Evaluate Cushing syndrome, thyroid disease, and other rare causes only when the history, examination, or baseline testing points toward the disorder. Cushing syndrome and thyroid disorders were among conditions sought in systematic resistant-hypertension evaluations.AHA JournalsObstructive Sleep Apnea | Hypertension For example, an adrenal lesion with evidence of cortisol nonsuppression requires assessment for cortisol co-secretion because primary aldosteronism and autonomous cortisol production can coexist.NatureA Case of Primary Aldosteronism Associated with Renal Artery Stenosis and Preclinical Cushing's Syndrome | Hypertension Research

Refer patients with confirmed or strongly suspected endocrine hypertension, equivocal ARR with persistent high pretest probability, suspected renovascular hypertension requiring an intervention decision, or refractory hypertension despite at least 5 drug classes including a long-acting thiazide or thiazide-like diuretic and a mineralocorticoid receptor antagonist.Nature2022 Renal denervation therapy for the treatment of hypertension Renal denervation is not a diagnostic substitute and should be avoided with unfavorable renal artery anatomy, heavily calcified or tortuous aorta, aortic aneurysm, prior dissection, increased bleeding risk, advanced CKD, pregnancy, or prior renal intervention.Nature2022 Renal denervation therapy for the treatment of hypertension

Escalation decisions after targeted secondary-cause testing.Nature2022 Renal denervation therapy for the treatment of hypertensionNatureInvestigation and management of resistant hypertension: British and Irish Hypertension Society position statement | Journal of Human HypertensionScienceDirectRenovascular Disease - an overview
SituationActionKey constraint
High pretest probability of pheochromocytomaMeasure plasma-free metanephrinesPlasma testing may be more sensitive but less specific than urinary testing.ScienceDirectRenovascular Disease - an overview
Lower pretest probability of pheochromocytomaConsider 24-hour urinary fractionated metanephrinesUrine testing may be preferred by some experts when suspicion is lower.ScienceDirectRenovascular Disease - an overview
True resistant hypertension after confirmation and evaluationAdd spironolactone when tolerated; use alternatives if contraindicated or not toleratedClinically significant hyperkalemia is a reason to avoid or discontinue mineralocorticoid receptor antagonism and seek specialist advice.NatureInvestigation and management of resistant hypertension: British and Irish Hypertension Society position statement | Journal of Human HypertensionWileyRevisiting resistant hypertension: a comprehensive review
Refractory hypertension despite 5 or more drug classes including thiazide-like diuretic and mineralocorticoid receptor antagonistRefer for advanced hypertension management; consider procedural options only after selection reviewRenal denervation requires suitable renal arterial anatomy and is contraindicated in several vascular, bleeding, pregnancy, and renal settings.Nature2022 Renal denervation therapy for the treatment of hypertension

Common questions

Should every patient with resistant hypertension undergo renal artery imaging?

No. Renal artery ultrasound or CT angiography is best directed by a renovascular clinical phenotype; these modalities are part of targeted secondary-cause assessment rather than universal screening.WileyAssociated factors and hemodynamic characteristics of resistant hypertension in the elderly

Does normal potassium exclude primary aldosteronism?

No. Primary aldosteronism commonly presents without classical hypokalemia, and resistant hypertension remains an indication for aldosterone-to-renin screening.AHA JournalsScreening Rates for Primary Aldosteronism in Resistant Hypertension | Hypertension

References

  1. Screening Rates for Primary Aldosteronism in Resistant Hypertension | Hypertensionwww.ahajournals.org · www.ahajournals.org
  2. Endocrine causes of hypertension: literature review and practical approach | Hypertension Researchwww.nature.com · www.nature.com
  3. Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines: Comparisons, Reflections, and Recommendations | JACCwww.jacc.org · www.jacc.org
  4. Assessing the Accuracy of an Online Chat-Based Artificial Intelligence Model in Providing Recommendations on Hypertension Management in Accordance With the 2017 American College of Cardiology/American Heart Association and 2018 European Society of Cardiology/European Society of Hypertension Guidelin...www.ahajournals.org · www.ahajournals.org
  5. Resistant Hypertension: Diagnosis, Evaluation, and Treatmentwww.ahajournals.org · www.ahajournals.org
  6. Obstructive Sleep Apnea | Hypertensionwww.ahajournals.org · www.ahajournals.org
  7. A Case of Primary Aldosteronism Associated with Renal Artery Stenosis and Preclinical Cushing's Syndrome | Hypertension Researchwww.nature.com · www.nature.com
  8. 2022 Renal denervation therapy for the treatment of hypertensionwww.nature.com · www.nature.com
  9. Investigation and management of resistant hypertension: British and Irish Hypertension Society position statement | Journal of Human Hypertensionwww.nature.com · www.nature.com
  10. Successful treatment of resistant hypertension and severe complications in a 63-year-old man with primary aldosteronism without adrenalectomy: A case reportwww.cell.com · www.cell.com
  11. Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines: Comparisons, Reflections, and Recommendationswww.sciencedirect.com · www.sciencedirect.com
  12. Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines | European Heart Journal | Oxford Academicacademic.oup.com · academic.oup.com
  13. 2021 European Society of Hypertension practice... : Journal of Hypertensionjournals.lww.com · journals.lww.com
  14. The double challenge of resistant hypertension and chronic kidney disease - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  15. Secondary hypertension: Obstructive sleep apnea - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  16. Renovascular Disease - an overviewwww.sciencedirect.com · www.sciencedirect.com
  17. Associated factors and hemodynamic characteristics of resistant hypertension in the elderlyonlinelibrary.wiley.com · onlinelibrary.wiley.com
  18. Case series: Primary aldosteronism diagnosed despite normal ... : Medicinejournals.lww.com · journals.lww.com
  19. Revisiting resistant hypertension: a comprehensive reviewonlinelibrary.wiley.com · onlinelibrary.wiley.com
  20. Abstract - 2025 - European Journal of Heart Failureonlinelibrary.wiley.com · onlinelibrary.wiley.com
  21. Drug Therapy for Resistant Hypertension: Simplifying the Approachonlinelibrary.wiley.com · onlinelibrary.wiley.com
  22. Primary hyperaldosteronism presenting as... : Medicine: Case Reports and Study Protocolsjournals.lww.com · journals.lww.com
  23. Clinical practice guideline for the management of hypertension in ...journals.lww.com · journals.lww.com
  24. HYPERTENSIVE EMERGENCY DUE TO RESISTANT ...journal.chestnet.org · journal.chestnet.org